Neuroscience
-
Scripps Research Finds STING Protein Fuels Alzheimer’s Inflammation
LA JOLLA, June 5 — A research team at Scripps Research has identified a specific biochemical alteration that drives chronic inflammation in…
-
Single Molecule Key to Stopping Alzheimer’s Brain Inflammation
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
-
Scripps Research Discovery Shifts Alzheimer’s Focus from Plaques to Inflammation
La Jolla, June 5, 2026 — cybernewschronicle.com — For years, the dominant theory behind Alzheimer’s disease has centered on sticky protein clumps…
-
Breakthrough Study Challenges Notion of Irreversible Paralysis and Nerve Damage
For many years the prevailing view held that once nerve pathways in the brain or spinal cord are cut, they cannot regenerate,…
-
Swiss Brain Implant Allows Paralyzed Man to Walk Naturally
On May 24, 2023, researchers in Switzerland announced a significant medical milestone. A man who had been paralyzed regained the ability to…
-
Brain Implant Restores Walking in Paralyzed Man
The Swiss breakthrough that put a paralyzed man back on his feet last week is already sending tremors through the medical world—not…
-
Swiss Brain Implants Restore Paralyzed Man’s Walking
May 24, 2023 — infopulsetoday.com — A groundbreaking medical breakthrough has been achieved by Swiss scientists, who have successfully enabled a paralyzed…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds







